Naito Shinsaku | Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
スポンサーリンク
概要
- 同名の論文著者
- Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)の論文著者
関連著者
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Naito Shinsaku
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
SAGAMI Fumio
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Ohkura Takako
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Mutai Mamoru
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
KOTOSAI Kounori
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KAWAHARA Jun-ichi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
INOUE Akiharu
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
OHKURA Takako
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KOHIRA Terutomo
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NAGAKI Yasuhiro
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NEMOTO Shingo
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
MATSUMOTO Shinichi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NAITO Shinsaku
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Kawahara Jun-ichi
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Onodera H
Pharmaceuticals And Medical Devices Agency
-
Inoue Akiharu
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Nemoto Shingo
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Furuta Shigeru
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Kohira Terutomo
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Onodera Hiroshi
Dvision Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
Nagaki Yasuhiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kotosai Kounori
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Onodera Hiroshi
Pharmaceutical And Medical Devices Agency
-
Matsumoto Shinichi
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Minagawa Toshiya
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Iwasa Takashi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Koga Toshihisa
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
NAKANO Kenji
Pharmaceuticals and Medical Devices Agency (PMDA)
-
FURUTA Shigeru
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
TAKEKAWA Koji
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
MINATO Kouichi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
SATO Takashi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
KAWASHIMA Kosuke
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
KURAHASHI Yoshikazu
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
NAKAMURA Kazuichi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
Takekawa Koji
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Minato Kouichi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Kurahashi Yoshikazu
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Furuta Shigeru
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Nakamura Kazuichi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
Sato Takashi
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
OHKURA Takako
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
著作論文
- S3-6 Problems and Meanings of Genome-based Drug Discovery in Japanese Pharmaceutical Companies(SYMPOSIUM 3: BENEFITS OF PHARMACOGENOMICS/PHARMACOGENETICS IN PHARMACEUTICAL DEVELOPMENT)(Proceedings of the 31st Annual Meeting)
- Perspectives on non-clinical safety evaluation of drug metabolites through the JSOT workshop